Complement, age-related macular degeneration and a vision of the future.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  A M A Archives of Ophthalmology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1001/archophthalmol.2010.18PMID 20212207PMCID PMC4405117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular pathology of age-related macular degeneration.

  2009cited by this paper
• Development and application of genotyping technologies

  2009cited by this paper
• Association of HTRA1 and ARMS2 gene variation with drusen formation in rhesus macaques.

  2009cited by this paper
• Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables.

  2009cited by this paper
• Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy

  2009cited by this paper
• Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study.

  2009cited by this paper
• Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration.

  2009cited by this paper
• Age-related macular degeneration.

  2008cited by this paper
• The spectrum of complement alternative pathway‐mediated diseases

  2008cited by this paper
• Genetics of age-related macular degeneration.

  2008cited by this paper
• Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab

  2008cited by this paper
• Age-related macular degeneration: a perspective on genetic studies

  2008cited by this paper
• Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss

  2008cited by this paper
• Advances in understanding of pathogenesis of aHUS and HELLP

  2008cited by this paper
• Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection.

  2008cited by this paper
• Complexity of complement activation in sepsis

  2008cited by this paper
• C3 R102G polymorphism increases risk of age-related macular degeneration.

  2008cited by this paper
• Interaction between the coagulation and complement system.

  2008cited by this paper
• Rhesus monkeys and humans share common susceptibility genes for age-related macular disease.

  2008cited by this paper
• Coagulation gene predictors of photodynamic therapy for occult choroidal neovascularization in age-related macular degeneration.

  2008cited by this paper
• Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA

  2008cited by this paper
• CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.

  2008cited by this paper
• Complement factor H polymorphisms, renal phenotypes and age-related macular degeneration: the Blue Mountains Eye Study

  2008cited by this paper
• Factor H family proteins and human diseases.

  2008cited by this paper
• Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration: a report by the American Academy of Ophthalmology.

  2008cited by this paper
• Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits.

  2007cited by this paper
• A clinician's view of the molecular genetics of age-related maculopathy.

  2007cited by this paper
• Variation in complement factor 3 is associated with risk of age-related macular degeneration

  2007cited by this paper
• Predictive value of multiple genetic testing for age-related macular degeneration.

  2007cited by this paper
• The role of complement in inflammatory diseases from behind the scenes into the spotlight.

  2007cited by this paper
• Complement C3 variant and the risk of age-related macular degeneration.

  2007cited by this paper
• An update on the genetics of age-related macular degeneration

  2007cited by this paper
• HTRA1 promoter polymorphism in wet age-related macular degeneration.

  2007cited by this paper
• Complement-targeted therapeutics

  2007cited by this paper
• Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration

  2007cited by this paper
• Review of Genetics in Age Related Macular Degeneration

  2007cited by this paper
• Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration.

  2007cited by this paper
• Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.

  2007cited by this paper
• Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.

  2007cited by this paper
• Dense deposit disease: new insights

  2007cited by this paper
• Overview of Progress in the Epidemiology of Age-Related Macular Degeneration

  2007cited by this paper
• The LOC387715 Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration

  2007cited by this paper
• Translational Mini‐Review Series on Complement Factor H: Genetics and disease associations of human complement factor H

  2007cited by this paper
• CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration

  2006cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration

  2006cited by this paper
• Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.

  2006cited by this paper
• The genetics of age-related macular degeneration: a review of progress to date.

  2006cited by this paper
• Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts

  2006cited by this paper
• HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration

  2006cited by this paper
• A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration

  2006cited by this paper
• The Role of Human HtrA1 in Arthritic Disease*

  2006cited by this paper
• A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

  2006cited by this paper
• Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications

  2006cited by this paper
• CFH Gene Variant, Y402H, and Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration

  2006cited by this paper
• CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration.

  2006cited by this paper
• Complement factor H polymorphisms in Japanese population with age-related macular degeneration.

  2006cited by this paper
• Decreased Thickness and Integrity of the Macular Elastic Layer of Bruch's Membrane Correspond to the

  2005cited by this paper
• Meta-analysis of genome scans of age-related macular degeneration.

  2005cited by this paper
• Susceptibility genes for age-related maculopathy on chromosome 10q26.

  2005cited by this paper
• Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration.

  2005cited by this paper
• Implications of the serine protease HtrA1 in amyloid precursor protein processing

  2005cited by this paper
• Complement Factor H Polymorphism in Age-Related Macular Degeneration

  2005cited by this paper
• Complement Factor H Polymorphism and Age-Related Macular Degeneration

  2005cited by this paper
• Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

  2005cited by this paper
• A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration.

  2005cited by this paper
• Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.

  2005cited by this paper
• Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk

  2005cited by this paper
• Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.

  2005cited by this paper
• Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions.

  2004cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• Allelic differences in hemolytic activity and protein concentration of BF molecules are found in association with particular HLA haplotypes

  2004cited by this paper
• VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2004cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.

  2002cited by this paper
• A role for local inflammation in the formation of drusen in the aging eye.

  2002cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

  2001cited by this paper
• Prospective study of dietary fat and the risk of age-related macular degeneration.

  2001cited by this paper
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.

  2001cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9.

  2001cited by this paper
• A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

  2001cited by this paper
• An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration.

  2001cited by this paper
• Complement activation and inflammatory processes in Drusen formation and age related macular degeneration.

  2001cited by this paper
• Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis

  2001cited by this paper
• Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease

  2000cited by this paper
• Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

  1999cited by this paper
• Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study.

  1998cited by this paper
• The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration.

  1998cited by this paper
• Family history and age-related maculopathy: the Blue Mountains Eye Study.

  1998cited by this paper
• The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration

  1998cited by this paper
• Genetic association of apolipoprotein E with age-related macular degeneration.

  1998cited by this paper
• Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration

  1997cited by this paper
• Age-related macular degeneration: genetics and implications for detection and treatment.

  1997cited by this paper
• Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration.

  1997cited by this paper
• Smoking and age-related maculopathy. The Blue Mountains Eye Study.

  1996cited by this paper
• Comparison of the binding of C3S and C3F to complement receptors types 1, 2, and 3.

  1995cited by this paper
• Molecular analysis of C3 allotypes in patients with systemic vasculitis.

  1994cited by this paper
• Is genetic predisposition an important risk factor in age-related macular degeneration?

  1994cited by this paper
• The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking.

  1993cited by this paper
• Molecular analysis of C3 allotypes in patients with nephritic factor

  1993cited by this paper
• The Human Genome Project and the future of medicine.

  1993cited by this paper

• Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities

  2026cites this paper
• The Role of Inflammation in Age-Related Macular Degeneration.

  2025cites this paper
• Retinal prosthesis: a comprehensive review

  2025cites this paper
• Review: Mechanisms of TIMP-3 accumulation and pathogenesis in Sorsby fundus dystrophy

  2024cites this paper
• Systemic inflammatory regulators and age-related macular degeneration: a bidirectional Mendelian randomization study

  2024cites this paper
• The Impact of NF-κB on Inflammatory and Angiogenic Processes in Age-Related Macular Degeneration.

  2024cites this paper
• C5 inhibitor avacincaptad pegol treatment for geographic atrophy: A comprehensive review

  2024cites this paper
• The roadmap to geographic atrophy treatment: A journey of trials and promise

  2023cites this paper
• Systematic review and meta-analysis of mass spectrometry proteomics applied to ocular fluids to assess potential biomarkers of age-related macular degeneration

  2023cites this paper
• Targeting the complement system in geographic atrophy: mechanisms and therapeutics

  2023cites this paper
• What is on the horizon for dry age-related macular degeneration drug treatment?

  2023cites this paper
• Race-and Sex-related Differences in Retinal Thickness and Foveal Race-and Sex-related Differences in Retinal Thickness and Foveal Pit Morphology Pit Morphology

  2023cites this paper
• Neoteric Role Of Quercetin In Visual Disorders.

  2023cites this paper
• The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy

  2023cites this paper
• The modern view of the state of the problem of age-macular degeneration, its connection with genetics

  2023cites this paper
• Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H

  2023cites this paper
• Nutritional therapy in children with sepsis and septic shock: unresolved questions and the need for an individualized approach

  2023cites this paper
• Pegcetacoplan in the treatment of geographic atrophy.

  2023cites this paper
• Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

  2023cites this paper
• Secretory autophagy: a turn key for understanding AMD pathology and developing new therapeutic targets?

  2022cites this paper
• Efficacy Analysis of Corneal Photo-vitrification (CPV) for Improved Vision of Age-related Macular Degeneration (AMD) Eyes

  2022cites this paper
• Molecular Genetic Mechanisms in Age-Related Macular Degeneration

  2022cites this paper
• Complement cascade inhibition in geographic atrophy: a review

  2022cites this paper
• Tissue engineering in age-related macular degeneration: a mini-review

  2022cites this paper
• Uncoupling Proteins as Therapeutic Targets for Neurodegenerative Diseases

  2022cites this paper
• Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions

  2021cites this paper
• Mitochondrial C3a Receptor Activation in Oxidatively Stressed Epithelial Cells Reduces Mitochondrial Respiration and Metabolism

  2021cites this paper
• Uncoupling proteins in the mitochondrial defense against oxidative stress.

  2021cites this paper
• [Pharmacological and physiotherapeutic methods of treating non-exudative age-related macular degeneration].

  2021cites this paper
• Gene Therapy in the Treatment of Geographic Atrophy.

  2021cites this paper
• Complement System and Potential Therapeutics in Age-Related Macular Degeneration

  2021cites this paper
• Histopathology of Age-Related Macular Degeneration and Implications for Pathogenesis and Therapy.

  2021cites this paper
• Emerging Protein Biomarkers for the Diagnosis or Prediction of Gestational Diabetes—A Scoping Review

  2021cites this paper
• Characteristics of Pachychoroid Diseases and Age-Related Macular Degeneration: Multimodal Imaging and Genetic Backgrounds

  2020cites this paper
• Distinct effects of complement and of NLRP3- and non-NLRP3 inflammasomes for choroidal neovascularization

  2020cites this paper
• Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients

  2020cites this paper
• Drug Delivery Challenges and Novel Therapeutic Approaches for Retinal Diseases

  2020cites this paper
• [Vision pathologies].

  2020cites this paper
• Macular Degeneration and Treatment

  2020cites this paper
• P2X7 Receptor Antagonist Attenuates Retinal Inflammation and Neovascularization Induced by Oxidized Low Density Lipoprotein

  2020cites this paper
• Progress in the Treatment of Dry Age-Related Macular Degeneration

  2020cites this paper
• Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients

  2020cites this paper
• A Multi-Omics Approach Identifies Key Regulatory Pathways Induced by Long-Term Zinc Supplementation in Human Primary Retinal Pigment Epithelium

  2020cites this paper
• Age-Related Macular Degeneration in Primary Osteoarthritis Egyptian Patients

  2020cites this paper
• Recent Developments in Agents for the Treatment of Age-Related Macular Degeneration and Stargardt Disease

  2020cites this paper
• Nove mogućnosti liječenja „suhe” senilne makularne degeneracije Novel possibilities in treatment of dry age-related macular degeneration

  2020cites this paper
• Evaluation of a deep learning system for the joint automated detection of diabetic retinopathy and age‐related macular degeneration

  2019cites this paper
• Retinal microglia – A key player in healthy and diseased retina

  2019cites this paper
• Medikamentöse Therapieansätze für die nicht neovaskuläre AMD Pharmacotherapy of Non-neovascular AMD

  2019cites this paper
• Medikamentöse Therapieansätze für die nicht neovaskuläre AMD Pharmacotherapy of Non-neovascular AMD

  2019cites this paper
• Implantation of electronic visual prosthesis for blindness restoration

  2019cites this paper
• Medikamentöse Therapieansätze für die nicht neovaskuläre AMD

  2019cites this paper
• Novel possibilities in treatment of dry age-related macular degeneration

  2019cites this paper
• New Therapeutic Approaches Against Ocular Diseases

  2019cites this paper
• Progranulin and Central Nervous System Disorders

  2019cites this paper
• Concise Review: Update on Retinal Pigment Epithelium Transplantation for Age‐Related Macular Degeneration

  2019cites this paper
• Intermediate Uveitis : Etiology , Diagnosis , and Treatment

  2018cites this paper
• Quantitative proteomic analysis of aqueous humor from patients with drusen and reticular pseudodrusen in age-related macular degeneration

  2018cites this paper
• Comparison of Monophasic and Biphasic Electrical Stimulation by Using Temporal Analysis for Different Inter-electrode Spacings in the Hexagonal Arrays

  2018cites this paper
• Ophtalmologie. La dégénérescence maculaire liée à l’âge et la voie du complément : où en est-on en 2017 ?

  2018cites this paper
• Complement-Mediated Activation of the NLRP3 Inflammasome and Its Inhibition by AAV-Mediated Delivery of CD59 in a Model of Uveitis.

  2018cites this paper
• The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates

  2018cites this paper
• A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle

  2018cites this paper
• Exergaming: Effects on Elderly in a Smart Gym Environment

  2018cites this paper
• A long history of dense deposit disease

  2018cites this paper
• The impact of genome-wide association studies on biomedical research publications

  2017cites this paper
• Long non‑coding RNA associated‑competing endogenous RNAs are induced by clusterin in retinal pigment epithelial cells.

  2017cites this paper
• Recent advances in the management of dry age-related macular degeneration: A review

  2017cites this paper
• Pharmacologic Treatment of Wet Type Age-related Macular Degeneration; Current and Evolving Therapies.

  2017cites this paper
• Flexible microelectrode array for retinal prosthesis

  2017cites this paper
• miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD)

  2017cites this paper
• A Review of Current and Future Management of Geographic Atrophy

  2017cites this paper
• Pixel Characterization of a Protein-Based Retinal Implant Using a Microfabricated Sensor Array

  2017cites this paper
• Association of CFI p.Gly119Arg gene polymorphism with age-related macular degeneration (AMD) disease in the population living in Tehran

  2017cites this paper
• 7.34 Retina Reconstruction

  2017cites this paper
• همراهی پلیمورفیسم p.Gly119Arg ژن CFI در مبتلایان به بیماری دژنراسیون ماکولای وابسته به سن در جمعیت ساکن در شهر تهران

  2017cites this paper
• Vers un traitement personnalisé de la dégénérescence maculaire liée à l’âge

  2017cites this paper
• Comparison of Monophasic and Biphasic Electrical Stimulation by Using Temporal Analysis for Different Inter-electrode Spacings in the Hexagonal Arrays

  2017cites this paper
• Reflections on "Hot" Blind Spots: Lessons from Research on Aging Macula Disorder and Glaucoma

  2017cites this paper
• Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics

  2016cites this paper
• Bioelectronic retinal prosthesis

  2016cites this paper
• Cellular Responses of the Retina to West Nile Virus Infection

  2016cites this paper
• Complement factor H and susceptibility to major depressive disorder in Han Chinese

  2016cites this paper
• Effect of ARMS 2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration

  2016cites this paper
• Highlights from a Roundtable Discussion

  2016cites this paper
• DIET AND NUTRITION SUPPLEMENTATION IN AGE-RELATED MACULAR DEGENERATION

  2016cites this paper
• Inflammation and its role in age-related macular degeneration

  2016cites this paper
• Effect of ARMS2 gene polymorphism on intravitreal ranibizumab treatment for neovascular age-related macular degeneration.

  2016cites this paper
• Retina Pathological Effects of Mutant C 1 QTNF 5 ( S 163 R ) Expression in Murine Retinal Pigment Epithelium

  2015cites this paper
• Complement regulator CD46: genetic variants and disease associations

  2015cites this paper
• Impact of visceral fat and pro‐inflammatory factors on the pathogenesis of age‐related macular degeneration

  2015cites this paper
• Combined effects of genetic and non‐genetic risk factors affect response to ranibizumab in exudative age‐related macular degeneration

  2015influential citation
• Association Study of Mannose-Binding Lectin Levels and Genetic Variants in Lectin Pathway Proteins with Susceptibility to Age-Related Macular Degeneration: A Case-Control Study

  2015cites this paper
• Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis

  2015cites this paper
• Pathological Effects of Mutant C1QTNF5 (S163R) Expression in Murine Retinal Pigment Epithelium.

  2015cites this paper
• A 0.5 V/1.8 V High Dynamic Range CMOS Imager for Artificial Retina Applications

  2015cites this paper
• Association between a functional genetic polymorphism ( rs 2230199 ) and age-related macular degeneration risk : a meta-analysis

  2015cites this paper
• Avaliação do polimorfismo Y402H no gene CFH e da deleção dos genes CFHR3/CFHR1 em relação à etiologia da degeneração macular relacionada a idade (DMRI) em uma amostra da população brasileira

  2015cites this paper
• What may and may not be feasible to minimize the worsening of geographic atrophy

  2015cites this paper
• Genotype‐directed therapy and age‐related‐macular degeneration: a cautionary note

  2015cites this paper